NCT02552745View on ClinicalTrials.gov

Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

April 30, 2015

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

parecoxib sodium

parecoxib sodium was administered postoperatively, when transcatheter arterial embolization finished.

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT02552745 - Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization | Biotech Hunter | Biotech Hunter